Clinical trial NCT01931644: At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Official title: A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: All Diagnosed Health Conditions
ADD/ADHD
Alopecia Areata
Ankylosing Spondylitis
Asthma
Atopic Dermatitis Eczema
Beta Thalassemia
Bipolar Disorder
Breast Cancer
Celiac Disease
Cervical Cancer
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic Kidney Diseases
Chronic Obstructive Pulmonary Disease
Colon Cancer
Colorectal Cancer
Crohn's Disease
Cystic Fibrosis
Depression
Diabetes Mellitus
Duchenne Muscular Dystrophy
Endometriosis
Epilepsy
Facioscapulohumeral Muscular Dystrophy
G6PD Deficiency
General Anxiety Disorder
Hepatitis B
Hereditary Hemorrhagic Telangiectasia
HIV/AIDS
Human Papilloma Virus
Huntington's Disease
Idiopathic Thrombocytopenic Purpura
Insomnia
Kidney Cancer
Leukemia
Lung Cancer
Lupus Nephritis
Lymphoma
Melanoma
Multiple Myeloma
Multiple Sclerosis
Myositis
Myotonic Dystrophy
Ovarian Cancer
Pancreatic Cancer
Parkinson's Disease
Polycystic Kidney Diseases
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Rosacea
Scleroderma
Sickle Cell Anemia
Sickle Cell Trait
Sjogren's Syndrome
Skin Cancer
Spinal Muscular Atrophy
Systemic Lupus Erythematosus
Thrombotic Thrombocytopenic Purpura
Trisomy 21
Ulcerative Colitis
Keywords: ADD/ADHD
Alopecia Areata
Ankylosing Spondylitis
Asthma
Atopic Dermatitis Eczema
Beta Thalassemia
Bipolar Disorder
Breast Cancer
Celiac Disease
Cervical Cancer
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic Kidney Diseases
Chronic Obstructive Pulmonary Disease
Colon Cancer
Colorectal Cancer
Crohn's Disease
Cystic Fibrosis
Depression
Diabete Mellitus
Duchenne Muscular Dystrophy
Endometriosis
Epilepsy
Facioscapulohumeral Muscular Dystrophy
G6PD Deficiency
General Anxiety Disorder
Hepatitis B
Hereditary Hemorrhagic Telangiectasia
HIV/AIDS
Human Papilloma Virus
Huntington's Disease
Idiopathic Thrombocytopenic Purpura
Insomnia
Kidney Cancer
Leukemia
Lung Cancer
Lupus Nephritis
Lymphoma
Melanoma
Multiple Myeloma
Multiple Sclerosis
Myositis
Myotonic Dystrophy
Ovarian Cancer
Pancreatic Cancer
Parkinson's Disease
Polycystic Kidney Diseases
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Rosacea
Scleroderma
Sickle Cell Anemia
Sickle Cell Disease
Sickle Cell Trait
Sjogren's Syndrome
Skin Cancer
Spinal Muscular Atrophy
Systemic Lupus Erythematosus
Thrombotic Thrombocytopenic Purpura
Trisomy 21
Ulcerative Colitis
Lead sponsor: Sanguine Biosciences
Sponsor class: INDUSTRY
First posted: 2013-08-29
Enrollment: 17667
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: Diagnosed with a health condition

Brief summary: We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Detailed description: This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

Eligibility criteria: Inclusion Criteria:

* All adults 18-100 years old
* Able to provide proof of diagnosis
* Live in USA

Exclusion Criteria:

* Younger than 18 years old
* Receipt of blood products within 30 days of study blood collection
* Receipt of investigational drug within 30 days of study blood collection

Primary outcomes:
measure: Biospecimen & Clinical Data Collection
timeFrame: 10 years
Secondary outcomes:
Other outcomes:
Locations:
city: Los Angeles
country: United States
facility: Sanguine Biosciences
state: California
Study officials:
affiliation: Sanguine Biosciences
name: Houman Hemmati, MD
role: PRINCIPAL_INVESTIGATOR
References: